Revolutionizing Parkinson’s Care: A Bold New Study Using Real-World Data

Newel Health's Innovative Approach to Parkinson's Disease Treatment

2 mins read

Key Takeaways:

  1. Launch of “NWL-SOT-CS-001” clinical study by Newel Health, focusing on Real-World Data for Parkinson’s treatment.
  2. Generous funding from The Michael J. Fox Foundation for this groundbreaking research.
  3. Recruitment and data collection phases initiated, utilizing Soturi mobile app and smart devices for a comprehensive study.

Introduction to a Groundbreaking Study

In a significant development, Newel Health, a pioneer in digital therapeutic solutions, has announced the launch of a landmark clinical study, “NWL-SOT-CS-001”. This study, conducted at three renowned centers in Italy, is poised to revolutionize the treatment strategies for Parkinson’s disease.

Leveraging Real-World Data for Enhanced Understanding

The study is uniquely designed to prioritize free-living data collection. By understanding patients’ daily challenges and medication response patterns, Newel Health aims to refine treatment algorithms, offering a more personalized approach to managing Parkinson’s disease.

Partnership with Eminent Research Centers

Led by Prof. Maria Teresa Pellecchia at University Hospital San Giovanni di Dio e Ruggi d’Aragona in Salerno, and involving two other centers in Rome, this collaborative effort underscores the commitment to advancing Parkinson’s disease treatment.

Funding and Support from The Michael J. Fox Foundation

The Michael J. Fox Foundation for Parkinson’s Research, known for its dedication to finding a cure for Parkinson’s disease, has generously funded this study. This support highlights the project’s significance in the medical community.

The Role of Soturi Mobile App in Data Collection

Central to the study is the Soturi mobile app, paired with a wearable smart device. This digital toolkit will capture comprehensive data over a 6-month period, allowing researchers to analyze symptom patterns and medication adherence in real-world scenarios.

See also  Revealing the True Face of Psychological Safety in the Workplace

Prof. Maria Teresa Pellecchia’s Vision

Prof. Pellecchia, the study’s Principal Investigator, emphasizes the importance of this research: “We aim to address the unmet need for accurate identification and remote monitoring of Parkinson’s symptoms in real-world settings. Soturi’s digital health technology is pivotal in providing real-time insights for optimizing medication schedules.”

Dr. Clelia Pellicano on Ecological Data Collection

Dr. Pellicano, another Principal Investigator, highlights the need to base insights on ecological data. She mentions, “Our goal is to provide a comprehensive understanding through accurate reports of patient symptomatology in everyday contexts.”

Clinical Trial Manager Giovanni Gentile’s Role

Giovanni Gentile, Clinical Trial Manager at Newel Health, speaks about the study’s significance in implementing digital data collection and the importance of Real-World Data in understanding Parkinson’s disease.

About Newel Health and Its Mission

Newel Health, with a history of strategic acquisitions and a team of experts in various fields, is dedicated to improving the lives of people living with health conditions. Their focus on patient-centricity and partnerships in the life sciences industry has led to successful outcomes.

Digital Solutions by Newel Health

Newel Health offers innovative digital solutions like Amicomed and Soturi, aimed at optimizing medication and treatment plans. Their proprietary rapid-development SaMD framework, H.Core, accelerates the design and launch of these solutions.

Further Information and Participation

For more information or to participate in the study, visit:

Conclusion

This study by Newel Health, supported by The Michael J. Fox Foundation, represents a significant advancement in the treatment of Parkinson’s disease. Utilizing real-world data, it holds the promise of developing more effective, personalized treatment strategies for those afflicted by this condition.

See also  Revolutionizing Healthcare: New CEO to Propel Digital Therapeutics to New Heights

Sign up to our newsletter & get the most important monthly insights from around the world.


Ready to Amplify Your Brand with Business Today?

Discover the power of sponsored articles and partnerships to reach decision-makers, professionals, and a dynamic audience. Learn more about our advertising opportunities and connect with us today!

Click here to explore our Promotion & Sponsored Articles page.

Are you looking to make an impact? Contact us at pitch@businesstoday.news to get started!

See also  Tech Titan Revolutionizes Broadcasting: A Game-Changer in Digital Content Management

Business Today News

BusinessToday.news is an online publication committed to delivering comprehensive and insightful coverage of the latest business news, trends, and practices. With a focus on finance, technology, entrepreneurship, and other critical areas, it serves as a valuable resource for professionals seeking to stay abreast of the rapidly evolving business landscape.

Leave a Reply

Your email address will not be published.

Latest from Blog

About

BusinessToday.news is a premier online platform dedicated to providing the latest news and insights on a wide range of topics related to the business world, including technology, finance, real estate, healthcare, and more.

Newsletter

Copyright Unstructured.Media. All rights reserved. Explore our sitemap